
    
      Objective: To evaluate the effect of the combination of the antioxidant Ascorbic acid and
      tocopherol, as therapy of the depressive disorder in the elderly.

        -  Design: Pilot clinical trial, Phase II , 6-month randomized, double-blind
           placebo-controlled one-way crossover clinical trial, with two treatment periods of 12
           weeks duration.

        -  Setting: Regional University Hospital, Malaga.

        -  Subjects: people older tan 55 years diagnosed with depression.

        -  Intervention: 50 participants randomly assigned, to receive antioxidant vitamins C
           (ascorbic acid) and vitamin E (d-alpha-tocopherol) once a day or placebo for 12 weeks
           double-blind. In Study Period 2, all participants receive (open) active treatment.
           Outcome measures: improvement in depressive symptoms. Plasma antioxidant status, also
           memory will be assessed by Wechsler Memory Scale (WMS-III), and cognitive improvement
           will be analyzed using Mini mental state examination (MMSE) at 0, 3, 6 months during the
           trial.
    
  